4//SEC Filing
Sloan Sheldon 4
Accession 0001636282-24-000068
CIK 0001636282other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 6:34 PM ET
Size
5.7 KB
Accession
0001636282-24-000068
Insider Transaction Report
Form 4
Sloan Sheldon
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-01+400,000→ 400,000 totalExercise: $27.46Exp: 2034-10-01→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]This option represents the right to purchase 400,000 shares of the Issuer's common stock, one quarter of which will vest and become exercisable on October 1, 2025, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Documents
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0002038798
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 6:34 PM ET
- Size
- 5.7 KB